TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
6/20/24 17:27 | 6/17/24 | IRON | Disc Medicine, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Ashiya Mona | MA | D | P | 3,000 | 36.00 | 0 | 83 | 55 | 235 | I | |||||||||||||||
12/20/23 18:16 | 12/18/23 | IRON | Disc Medicine, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Ashiya Mona | MA | D | M.d | 66 | 38.00 | 0 | 2 | 0 | 1,702 | D | |||||||||||||||
12/20/23 18:16 | 12/18/23 | IRON | Disc Medicine, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Ashiya Mona | MA | D | S.d | -102 | 59.24 | 0 | -2 | 0 | 1,702 | D | |||||||||||||||
12/15/23 18:09 | 12/14/23 | IRON | Disc Medicine, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Ashiya Mona | MA | D | S | -24,584 | 56.75 | 0 | -433 | -66 | 224 | I | |||||||||||||||
12/14/23 17:40 | 12/12/23 | IRON | Disc Medicine, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Ashiya Mona | MA | D | S.m | -7,902 | 58.88 | 0 | -134 | -16 | 728 | I | |||||||||||||||
2/17/23 16:48 | 2/15/23 | IRON | Disc Medicine, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Ashiya Mona | MA | DT | P | 2,500 | 23.00 | 0 | 109 | 57 | 299 | I |
D | Derivative transaction in filing (usually option exercise) |
M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
A | Amended filing |
E | Error detected in filing |
S - Sale | Sale of securities on an exchange or to another person |
S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
P - Purchase | Purchase of securities on an exchange or from another person |